| Name | N-methyl-2-nitro-4-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxyaniline |
|---|---|
| Synonyms |
BENZENAMINE,N-METHYL-2-NITRO-4-[[2-[5-(TRIFLUOROMETHYL)-1H-IMIDAZOL-2-YL]-4-PYRIDINYL]OXY]
4-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-methyl-2-nitrobenzenamine |
| Molecular Formula | C16H12F3N5O3 |
|---|---|
| Molecular Weight | 379.29300 |
| Exact Mass | 379.08900 |
| PSA | 108.65000 |
| LogP | 4.82890 |
|
~41%
927880-88-4 |
| Literature: Novartis AG Patent: US2007/49622 A1, 2007 ; Location in patent: Page/Page column 42 ; |
|
~%
927880-88-4 |
| Literature: NOVARTIS AG Patent: WO2008/11154 A2, 2008 ; Location in patent: Page/Page column 28 ; |
|
~%
927880-88-4 |
| Literature: Novartis AG Patent: US2007/49622 A1, 2007 ; Location in patent: Page/Page column 19 ; |
|
~%
927880-88-4 |
| Literature: NOVARTIS AG Patent: WO2008/140850 A1, 2008 ; Location in patent: Page/Page column 60 ; WO 2008/140850 A1 |
| Precursor 5 | |
|---|---|
| DownStream 0 | |